Burkholderia cepacia complex: Beyond pseudomonas and acinetobacter

Indian Journal of Medical Microbiology

Volumn 29, Issue 1, 2011, Pages 4-12

  Gautam, V ^a   Singhal, L ^a   Ray, P ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Burkholderia cepacia complex; cystic fibrosis; nonfermenter; septicaemia

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; DORIPENEM; MEROPENEM; MINOCYCLINE; PENICILLIN DERIVATIVE; POLYMYXIN DERIVATIVE; TOBRAMYCIN;

ACINETOBACTER; ACINETOBACTER INFECTION; AGRICULTURE; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL THERAPY; AUTOMATION; BACTEREMIA; BACTERIAL ARTHRITIS; BIOREMEDIATION; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA CEPACIA INFECTION; CYSTIC FIBROSIS; GRAM NEGATIVE BACTERIUM; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; LABORATORY TEST; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PATHOGENESIS; PSEUDOMONAS; PSEUDOMONAS INFECTION; RESPIRATORY TRACT INFECTION; REVIEW; SEPTICEMIA; URINARY TRACT INFECTION;

EID: 79951978617     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.76516     Document Type: Review

References (54)

1. Govan JR, Vandamme P. Agricultural and medical microbiology: a time for bridging gaps. Microbiology 1998;144:2373-5. (Pubitemid 28457146)
2. Slama TG. Gram-negative antibiotic resistance: there is a price to pay. Crit Care Med 2008;12:4.
3. Burkholder W. Sour skin, a bacterial rot of onion bulbs. Phytopathology 1950;40:115-8.
4. LiPuma JJ CB, Lum GD, Vandamme PAR. Burkholderia, Stenotrophomonas, Ralstonia, Cupriavidus, Pandoraea, Brevundimonas, Comamonas and Acidovorax. In: Murray PR BE, Jorgensen JH, Landry ML, Pfaller MA, editors. Manual of clinical Microbiology. Washington, DC: ASM Press; 2007. p. 749-69.
5. Doit C, Loukil C, Simon AM, Ferroni A, Fontan JE, Bonacorsi S, et al. Outbreak of Burkholderia cepacia bacteremia in a pediatric hospital due to contamination of lipid emulsion stoppers. J Clin Microbiol 2004;42:2227-30. (Pubitemid 38637850)
6. Abe K, D'Angelo MT, Sunenshine R, Noble-Wang J, Cope J, Jensen B, et al. Outbreak of Burkholderia cepacia bloodstream infection at an outpatient hematology and oncology practice. Infect Control Hosp Epidemiol 2007;28:1311-3. (Pubitemid 47596572)
7. LiPuma JJ, Mahenthiralingam E. Commercial use of Burkholderia cepacia. Emerg Infect Dis 1999;5:305-6.
8. Gautam V, Arora A, Madhup SK, Das A, Vandamme P, Sharma K, et al. Burkholderia cepacia complex in septicaemic non-cystic fibrosis cases from two tertiary care hospitals in north India. Indian J Med Res 2010;131:829-32.
9. Gautam V, Ray P, Das A, Vandamme P, Malhotra P, Varma S, et al. Two cases of Burkholderia cenocepacia in septicemic patients. Jpn J Infect Dis 2008;61:133-4. (Pubitemid 351663808)
10. Gautam V, Ray P, Puri GD, Sharma K, Vandamme P, Madhup SK, et al. Investigation of Burkholderia cepacia complex in septicaemic patients in a tertiary care hospital, India. Nepal Med Coll J 2009;11:222-4.
11. Gautam V, Ray P, Vandamme P, Chatterjee SS, Das A, Sharma K, et al. Identification of lysine positive non-fermenting gram negative bacilli (Stenotrophomonas maltophilia and Burkholderia cepacia complex). Indian J Med Microbiol 2009;27:128-33.
12. Mukhopadhyay C, Bhargava A, Ayyagari A. Two novel clinical presentations of Burkholderia cepacia infection. J Clin Microbiol 2004;42:3904-5. (Pubitemid 39045745)
13. Mahenthiralingam E, Baldwin A, Dowson CG. Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology. J Appl Microbiol 2008;104:1539-51. (Pubitemid 351724983)
14. Sousa SA, Ramos CG, Leitao JH. Burkholderia cepacia complex: emerging multihost pathogens equipped with a wide range of virulence factors and determinants. Int J Microbiol 2011;2011. pii: 607575. Epub 2010 Aug 3.
15. Waine DJ, Henry DA, Baldwin A, Speert DP, Honeybourne D, Mahenthiralingam E, et al. Reliability of multilocus sequence typing of the Burkholderia cepacia complex in cystic fibrosis. J Cyst Fibros 2007;6:215-9. (Pubitemid 46567793)
16. Holmes A, Govan J, Goldstein R. Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health? Emerg Infect Dis 1998;4:221-7.
17. Baldwin A, Mahenthiralingam E, Drevinek P, Vandamme P, Govan JR, Waine DJ, et al. Environmental Burkholderia cepacia complex isolates in human infections. Emerg Infect Dis 2007;13:458-61. (Pubitemid 46348134)
18. LiPuma JJ, Spilker T, Gill LH, Campbell PW 3rd, Liu L, Mahenthiralingam E. Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am J Respir Crit Care Med 2001;164:92-6. (Pubitemid 33151304)
19. Mahenthiralingam E, Urban TA, Goldberg JB. The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Microbiol 2005;3:144-56. (Pubitemid 40207595)
20. Reik R, Spilker T, Lipuma JJ. Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis. J Clin Microbiol 2005;43:2926-8. (Pubitemid 40827976)
21. Govan JR, Brown AR, Jones AM. Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection. Future Microbiol 2007;2:153-64. (Pubitemid 46766989)
22. Speert DP, Henry D, Vandamme P, Corey M, Mahenthiralingam E. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg Infect Dis 2002;8:181-7. (Pubitemid 34202443)
23. Mahenthiralingam E, Simpson DA, Speert DP. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol 1997;35:808-16. (Pubitemid 27146516)
24. Mahenthiralingam E, Bischof J, Byrne SK, Radomski C, Davies JE, Av-Gay Y, et al. DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol 2000;38:3165-73.
25. Baldwin A, Mahenthiralingam E, Drevinek P, Pope C, Waine DJ, Henry DA, et al. Elucidating global epidemiology of Burkholderia multivorans in cases of cystic fibrosis by multilocus sequence typing. J Clin Microbiol 2008;46:290-5.
26. Govan JR, Brown PH, Maddison J, Doherty CJ, Nelson JW, Dodd M, et al. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993;342:15-9. (Pubitemid 23183915)
27. Mahenthiralingam E, Vandamme P, Campbell ME, Henry DA, Gravelle AM, Wong LT, et al. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans. Clin Infect Dis 2001;33:1469-75. (Pubitemid 34246138)
28. Coenye T, LiPuma JJ. Population structure analysis of Burkholderia cepacia genomovar III: varying degrees of genetic recombination characterize major clonal complexes. Microbiology 2003;149:77-88. (Pubitemid 36175679)
29. Ledson MJ, Gallagher MJ, Jackson M, Hart CA, Walshaw MJ. Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre. Thorax 2002;57:142-5. (Pubitemid 34123888)
30. Chen JS, Witzmann KA, Spilker T, Fink RJ, LiPuma JJ. Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. J Pediatr 2001;139:643-9. (Pubitemid 33097427)
31. Lipuma JJ. Preventing Burkholderia cepacia complex infection in cystic fibrosis: is there a middle ground? J Pediatr 2002;141:467-9.
32. Clode FE, Kaufmann ME, Malnick H, Pitt TL. Distribution of genes encoding putative transmissibility factors among epidemic and nonepidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom. J Clin Microbiol 2000;38:1763-6. (Pubitemid 30253911)
33. O'Sullivan LA, Weightman AJ, Jones TH, Marchbank AM, Tiedje JM, Mahenthiralingam E. Identifying the genetic basis of ecologically and biotechnologically useful functions of the bacterium Burkholderia vietnamiensis. Environ Microbiol 2007;9:1017-34. (Pubitemid 46397098)
34. Maschmeyer G. Mandell: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Philadelphia, Pennsylvania: Elsevier Churchill Livingstone; 2009. Chapter no. 220.
35. Bressler AM, Kaye KS, LiPuma JJ, Alexander BD, Moore CM, Reller LB, et al. Risk factors for Burkholderia cepacia complex bacteremia among intensive care unit patients without cystic fibrosis: a case-control study. Infect Control Hosp Epidemiol 2007;28:951-8. (Pubitemid 47218275)
36. Henderson DK, Baptiste R, Parrillo J, Gill VJ. Indolent epidemic of Pseudomonas cepacia bacteremia and pseudobacteremia in an intensive care unit traced to a contaminated blood gas analyzer. Am J Med 1988;84:75-81.
37. The nonfermentative gram-negative bacilli. In: Winn W AS, Jande W, Koneman E, Procop G, Schrekernbenger P, Woods G, editors. Koneman's Color Atlas and textbook of Diagnostic Microbiology. Baltimore, USA: Lippincott Williams and Wilkins Publishers; 2006. P. 303-91.
38. Kabra SK, Kabra M, Lodha R, Shastri S, Ghosh M, Pandey RM, et al. Clinical profile and frequency of delta f508 mutation in Indian children with cystic fibrosis. Indian Pediatr 2003;40:612-9. (Pubitemid 36898761)
39. Mehta S, Wadhwa UN, Mehta SK, Chhuttani PN. Fibrocystic disease of pancreas in India. Indian Pediatr 1968;5:185-91.
40. Henry D, Campbell M, McGimpsey C, Clarke A, Louden L, Burns JL, et al. Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol 1999;37:1004-7. (Pubitemid 29140605)
41. Lynch KH, Dennis JJ. Development of a species-specific fur gene-based method for identification of the Burkholderia cepacia complex. J Clin Microbiol 2008;46:447-55. (Pubitemid 351231285)
42. McMenamin JD, Zaccone TM, Coenye T, Vandamme P, LiPuma JJ. Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates. Chest 2000;117:1661-5. (Pubitemid 30413360)
43. Jorda-Vargas L, Degrossi J, Castaneda NC, D'Aquino M, Valvano MA, Procopio A, et al. Prevalence of indeterminate genetic species of Burkholderia cepacia complex in a cystic fibrosis center in Argentina. J Clin Microbiol 2008;46:1151-2. (Pubitemid 351380022)
44. Mahenthiralingam E, Baldwin A, Vandamme P. Burkholderia cepacia complex infection in patients with cystic fibrosis. J Med Microbiol 2002;51:533-8. (Pubitemid 34747981)
45. Mahenthiralingam E, Campbell ME, Henry DA, Speert DP. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. J Clin Microbiol 1996;34:2914-20. (Pubitemid 26389333)
46. Martins KM, Fongaro GF, Dutra Rodrigues AB, Tateno AF, Azzuz-Chernishev AC, de Oliveira-Garcia D, et al. Genomovar status, virulence markers and genotyping of Burkholderia cepacia complex strains isolated from Brazilian cystic fibrosis patients. J Cyst Fibros 2008;7:336-9.
47. Baldwin A, Mahenthiralingam E, Thickett KM, Honeybourne D, Maiden MC, Govan JR, et al. Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex. J Clin Microbiol 2005;43:4665-73. (Pubitemid 41298260)
48. Spilker T, Baldwin A, Bumford A, Dowson CG, Mahenthiralingam E, LiPuma JJ. Expanded multilocus sequence typing for Burkholderia species. J Clin Microbiol 2009;47:2607-10.
49. Nzula S, Vandamme P, Govan JR. Influence of taxonomic status on the in vitro antimicrobial susceptibility of the Burkholderia cepacia complex. J Antimicrob Chemother 2002;50:265-9.
50. Lambiase A, Raia V, Stefani S, Sepe A, Ferri P, Buonpensiero P, et al. Burkholderia cepacia complex infection in a cohort of Italian patients with cystic fibrosis. J Microbiol 2007;45:275-9. (Pubitemid 47037764)
51. Chen Y, Garber E, Zhao Q, Ge Y, Wikler MA, Kaniga K, et al. In vitro activity of doripenem (S-4661) against multidrug-resistant gram-negative bacilli isolated from patients with cystic fibrosis. Antimicrob Agents Chemother 2005;49:2510-1.
52. Performance standards for antimicrobial susceptibility testing; Twentieth informational supplement. Clinical and Laboratory Standards Institute (CLSI): Wayne, PA; 2010.
53. Saiman L, Siegel J. Infection control in cystic fibrosis. Clin Microbiol Rev 2004;17:57-71. (Pubitemid 38120929)
54. Agodi A, Barchitta M, Giannino V, Collura A, Pensabene T, Garlaschi ML, et al. Burkholderia cepacia complex in cystic fibrosis and non-cystic fibrosis patients: identification of a cluster of epidemic lineages. J Hosp Infect 2002;50:188-95. (Pubitemid 37554873)